Article Versions Notes

Longoria V, Parcel H, Toma B, Minhas A, Zeine R. Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination. Biomedicines. 2022; 10(3):539. https://doi.org/10.3390/biomedicines10030539

Longoria, Victor, Hannah Parcel, Bameelia Toma, Annu Minhas, and Rana Zeine. 2022. "Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination" Biomedicines 10, no. 3: 539. https://doi.org/10.3390/biomedicines10030539

Longoria, V., Parcel, H., Toma, B., Minhas, A., & Zeine, R. (2022). Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination. Biomedicines, 10(3), 539. https://doi.org/10.3390/biomedicines10030539